See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← CMCOM page
XStocksXray
Market X-Ray report · 23 October 2026

CM.com NV (CMCOM)

Euronext Amsterdam · Netherlands · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 6.370
52-week range3.970 – 7.600
Return, 1 month / 3 months−7.0% / −9.8%
Return, 1 year / 3 years+59.3% / −23.1%
TrendAbove 200-day, below 50-day
RSI (14)30
Volatility (1 year)36.3%
Worst drawdown (1 year)-20.5%
Average daily value traded0.10M EUR
Dividend yield–

Market X-Ray price-based

54/ 100 · High confidence · ahead of 50% of stocks on this exchange
Trend65
Momentum61
Stability (higher is calmer)52
Liquidity28
Income–

Five-year price chart navy: price · brown: 200-day average

2.389.8117.2424.6632.092021-112023-022024-052025-082026-10

About the company

CM.com is a Dutch software company based in Breda that provides cloud-based conversational commerce and payment services. It helps businesses communicate with their customers through messaging channels such as text messages, chat apps and voice, and it also processes payments. Its platform is used by organisations in retail, hospitality, travel and other consumer-facing sectors that want to handle customer contact, marketing and transactions in one place.

On this site CM.com NV appears as a stock on the Euronext Amsterdam (Netherlands), code CMCOM, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

CM.com NV (CMCOM) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 6.370 on 23 October 2026.

Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 55 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 59.3% and over the last three months it fell 9.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
CM.com NV (CMCOM)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam

Lens and metricValueScoreReading
Trend65 · FairMixed trend against its averages.
Above 200-day average2.2%
From 52-week high-14.2%
Momentum61 · FairTypical recent returns for this exchange.
3-month return-9.8%
6-month return5.6%
12-month return, skipping the last month71.3%
Stability (higher is calmer)52 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)36.3%
Worst drawdown, 1 year (smaller is calmer)-20.5%
Liquidity28 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.10M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−8.5%
1 month−7.0%
3 months−9.8%
6 months+5.6%
1 year+59.3%
3 years−23.1%
5 years−82.3%

Signals

50-day / 200-day average6.830 / 6.232
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.172

Technical summary

DailyBearish5 bullish · 0 neutral · 11 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026